Avid Bioservices Inc (CDMO)

[biopharm]

atonewithPPHM,

I believe the current President-elect of IASLC (David Carbone) and weeks away, soon to be President IASLC will have a major voice among oncologists world wide and what he says will be interesting to play out.

I did notice the title of David Carbones timeslot read:

"The Immune System and Lung Cancer", so I thought it was relevant and to be honest..... it could have read "Graphene Quantum Dots" and I'd probably still be interested. If what we are watching is simply the build of showing how important the immune system is, then at some point David Carbone will have to eventually slip up or be allowed to move forward and clearly show how PS Targeting allows for the optimal immune response, even if it is for a Astrazeneca drug... because they will need Bavi as well.

http://www.esmo.org/content/download/41727/790129/file/ESMO-Symposium-on-Immuno-Oncology-2014-Programme.pdf

-----------------------------------------------

Interesting note though....and just another piece to the puzzle, this profile only has 3 tweets and Bavi related and one of them mentions this webinar Monday the 24th

https://twitter.com/PeregrineASCO15